TRIDENT LIFELINE Q2 FY27 : CONS NET PROFIT UP 30% AT ₹6.6 CR (YOY), UP 30% (QOQ)

Revenue up 50% at ₹47.1 Cr (YOY), up 40% (QOQ). EBITDA up 65% at ₹11.3 Cr (YOY), up 33% (QOQ); margins 24.1% v 21.9% (YOY), 25.3% (QOQ). PAT margin 14.0% v 16.2% (YOY), 15.0% (QOQ). Parenterals facility expected to be commissioned after Diwali; proposed preferential issue to strengthen financial resources.

Trident Lifeline Ltd

Open attachment

← Back to feed